The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the closely watched treatment.

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining claims made in a U.S. broadcast that the inoculations have caused a sharp increase of “turbo cancer” in younger age groups.

The Food and Drug Administration (FDA) announced Wednesday it will ban Red No. 3, a common artificial food dye linked

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday after rising as much as 9.7% earlier. Over the past three years, the stock posted a daily gain of more than 8% only four times.

The artificial food dye can be found in candy, beverages, chips and other packaged foods — often consumed by children.

The FDA has banned red dye No. 3 in food and ingested drugs, the agency announced. But what exactly is red dye No. 3, and why is it being banned? Here's what you need to know.

Already banned in cosmetics and topical medicines since 1990, the Food and Drug Administration announced on Wednesday that Red 3 will now be banned in food, drink, and ingestible medications.

The U.S. Food and Drug Administration (FDA) is taking a stronger approach toward supporting health goals in 2025 and beyond by setting the tone

The U.S. on Wednesday banned the use of a synthetic food dye that gives some candies, cakes and certain oral medications a cherry-red color, following evidence that the dye causes cancer in laboratory rats.

The FDA has banned Red 3, a dye used in foods like candies and snack cakes, citing cancer risks observed in lab rats.